Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

Prioritizing therapeutics for lung cancer: an integrative meta-analysis of cancer gene signatures and chemogenomic data.

Fortney K, Griesman J, Kotlyar M, Pastrello C, Angeli M, Sound-Tsao M, Jurisica I.

PLoS Comput Biol. 2015 Mar 18;11(3):e1004068. doi: 10.1371/journal.pcbi.1004068. eCollection 2015 Mar.

2.

Potential role of CC chemokine receptor 6 in prediction of late-onset cytomegalovirus infection following solid organ transplant.

Camargo JF, Resende MR, Zamel R, Klement W, Bhimji A, Huibner S, Kumar D, Humar A, Jurisica I, Keshavjee S, Kaul R, Husain S.

Clin Transplant. 2015 Feb 17. doi: 10.1111/ctr.12531. [Epub ahead of print]

PMID:
25690781
3.

Where are we at regarding species translation? A review of the sbv IMPROVER challenge.

Hoeng J, Peitsch MC, Meyer P, Jurisica I.

Bioinformatics. 2015 Feb 15;31(4):451-2. doi: 10.1093/bioinformatics/btv065. Epub 2015 Jan 31. No abstract available.

PMID:
25638813
4.

Integrating RAS status into prognostic signatures for adenocarcinomas of the lung.

Starmans MH, Pintilie M, Chan-Seng-Yue M, Moon NC, Haider S, Nguyen F, Lau SK, Liu N, Kasprzyk A, Wouters BG, Der SD, Shepherd FA, Jurisica I, Penn LZ, Tsao MS, Lambin P, Boutros PC.

Clin Cancer Res. 2015 Mar 15;21(6):1477-86. doi: 10.1158/1078-0432.CCR-14-1749. Epub 2015 Jan 21.

PMID:
25609067
5.

Kinome-wide screening of HER2+ breast cancer cells for molecules that mediate cell proliferation or sensitize cells to trastuzumab therapy.

Lapin V, Shirdel EA, Wei X, Mason JM, Jurisica I, Mak TW.

Oncogenesis. 2014 Dec 15;3:e133. doi: 10.1038/oncsis.2014.45.

6.

Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.

Lalonde E, Ishkanian AS, Sykes J, Fraser M, Ross-Adams H, Erho N, Dunning MJ, Halim S, Lamb AD, Moon NC, Zafarana G, Warren AY, Meng X, Thoms J, Grzadkowski MR, Berlin A, Have CL, Ramnarine VR, Yao CQ, Malloff CA, Lam LL, Xie H, Harding NJ, Mak DY, Chu KC, Chong LC, Sendorek DH, P'ng C, Collins CC, Squire JA, Jurisica I, Cooper C, Eeles R, Pintilie M, Dal Pra A, Davicioni E, Lam WL, Milosevic M, Neal DE, van der Kwast T, Boutros PC, Bristow RG.

Lancet Oncol. 2014 Dec;15(13):1521-32. doi: 10.1016/S1470-2045(14)71021-6. Epub 2014 Nov 13.

7.

BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.

Dingar D, Kalkat M, Chan PK, Srikumar T, Bailey SD, Tu WB, Coyaud E, Ponzielli R, Kolyar M, Jurisica I, Huang A, Lupien M, Penn LZ, Raught B.

J Proteomics. 2015 Apr 6;118:95-111. doi: 10.1016/j.jprot.2014.09.029. Epub 2014 Oct 18.

PMID:
25452129
8.

NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer.

Berlin A, Lalonde E, Sykes J, Zafarana G, Chu KC, Ramnarine VR, Ishkanian A, Sendorek DH, Pasic I, Lam WL, Jurisica I, van der Kwast T, Milosevic M, Boutros PC, Bristow RG.

Oncotarget. 2014 Nov 30;5(22):11081-90.

9.

In silico prediction of physical protein interactions and characterization of interactome orphans.

Kotlyar M, Pastrello C, Pivetta F, Lo Sardo A, Cumbaa C, Li H, Naranian T, Niu Y, Ding Z, Vafaee F, Broackes-Carter F, Petschnigg J, Mills GB, Jurisicova A, Stagljar I, Maestro R, Jurisica I.

Nat Methods. 2015 Jan;12(1):79-84. doi: 10.1038/nmeth.3178. Epub 2014 Nov 17.

PMID:
25402006
10.

Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology.

Vucic EA, Thu KL, Pikor LA, Enfield KS, Yee J, English JC, MacAulay CE, Lam S, Jurisica I, Lam WL.

BMC Cancer. 2014 Oct 24;14:778. doi: 10.1186/1471-2407-14-778.

11.

Comparative network analysis via differential graphlet communities.

Wong SW, Cercone N, Jurisica I.

Proteomics. 2015 Jan;15(2-3):608-17. doi: 10.1002/pmic.201400233. Epub 2014 Dec 15.

12.

Knowledge Discovery and interactive Data Mining in Bioinformatics--State-of-the-Art, future challenges and research directions.

Holzinger A, Dehmer M, Jurisica I.

BMC Bioinformatics. 2014;15 Suppl 6:I1. doi: 10.1186/1471-2105-15-S6-I1. Epub 2014 May 16. No abstract available.

13.

Myc and its interactors take shape.

Tu WB, Helander S, Pilstål R, Hickman KA, Lourenco C, Jurisica I, Raught B, Wallner B, Sunnerhagen M, Penn LZ.

Biochim Biophys Acta. 2015 May;1849(5):469-483. doi: 10.1016/j.bbagrm.2014.06.002. Epub 2014 Jun 14. Review.

PMID:
24933113
14.

The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells.

Petschnigg J, Groisman B, Kotlyar M, Taipale M, Zheng Y, Kurat CF, Sayad A, Sierra JR, Mattiazzi Usaj M, Snider J, Nachman A, Krykbaeva I, Tsao MS, Moffat J, Pawson T, Lindquist S, Jurisica I, Stagljar I.

Nat Methods. 2014 May;11(5):585-92. doi: 10.1038/nmeth.2895. Epub 2014 Mar 23.

PMID:
24658140
15.

CHIP-MYTH: a novel interactive proteomics method for the assessment of agonist-dependent interactions of the human β₂-adrenergic receptor.

Kittanakom S, Barrios-Rodiles M, Petschnigg J, Arnoldo A, Wong V, Kotlyar M, Heisler LE, Jurisica I, Wrana JL, Nislow C, Stagljar I.

Biochem Biophys Res Commun. 2014 Mar 21;445(4):746-56. doi: 10.1016/j.bbrc.2014.02.033. Epub 2014 Feb 19.

PMID:
24561123
16.

Integration, visualization and analysis of human interactome.

Pastrello C, Pasini E, Kotlyar M, Otasek D, Wong S, Sangrar W, Rahmati S, Jurisica I.

Biochem Biophys Res Commun. 2014 Mar 21;445(4):757-73. doi: 10.1016/j.bbrc.2014.01.151. Epub 2014 Feb 1. Review.

PMID:
24491561
17.

Recurrent genomic alterations in sequential progressive leukoplakia and oral cancer: drivers of oral tumorigenesis?

Cervigne NK, Machado J, Goswami RS, Sadikovic B, Bradley G, Perez-Ordonez B, Galloni NN, Gilbert R, Gullane P, Irish JC, Jurisica I, Reis PP, Kamel-Reid S.

Hum Mol Genet. 2014 May 15;23(10):2618-28. doi: 10.1093/hmg/ddt657. Epub 2014 Jan 8.

18.

Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients.

Der SD, Sykes J, Pintilie M, Zhu CQ, Strumpf D, Liu N, Jurisica I, Shepherd FA, Tsao MS.

J Thorac Oncol. 2014 Jan;9(1):59-64. doi: 10.1097/JTO.0000000000000042.

PMID:
24305008
19.

Identifying Myc interactors.

Ponzielli R, Tu WB, Jurisica I, Penn LZ.

Methods Mol Biol. 2013;1012:51-64. doi: 10.1007/978-1-62703-429-6_4.

PMID:
24006057
20.

MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.

Goswami RS, Atenafu EG, Xuan Y, Waldron L, Reis PP, Sun T, Datti A, Xu W, Kuruvilla J, Good DJ, Lai R, Church AJ, Lam WS, Baetz T, Lebrun DP, Sehn LH, Farinha P, Jurisica I, Bailey DJ, Gascoyne RD, Crump M, Kamel-Reid S.

J Clin Oncol. 2013 Aug 10;31(23):2903-11. doi: 10.1200/JCO.2012.45.3050. Epub 2013 Jul 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk